CCL22 mutations drive natural killer cell lymphoproliferative disease by deregulating microenvironmental crosstalkConstance Baer, Charles G. Mullighan, Peter Chockley et al.|Nature Genetics|2022Cited by 42
CLL-156: Novel CCL22 Mutations Drive Chronic Lymphoproliferative Disorder of NK Cells Through Biased GPCR SignalingShunsuke Kimura, Charles G. Mullighan, Constance Baer et al.|Clinical Lymphoma Myeloma & Leukemia|2021Cited by 0
Poster: CLL-156: Novel CCL22 Mutations Drive Chronic Lymphoproliferative Disorder of NK Cells Through Biased GPCR SignalingShunsuke Kimura, Charles G. Mullighan, Constance Baer et al.|Clinical Lymphoma Myeloma & Leukemia|2021Cited by 0